Vaccination programs are considered a central pillar of the efforts to stop COVID-19. However, vaccine doses are scarce and several organizational and logistical obstacles, such as the timing of and reserves for second shots and delivery failures, apparently slow down vaccination roll-outs in several countries. Moreover, it is an open question as to where vaccines are administered as efficiently as possible (vaccination centers, hospitals, doctor’s offices, pharmacists, etc.). The first aim of our study was to systematically evaluate the efficiency of a country’s vaccination campaign. The second aim was to analyze how the integration of doctors’ offices into a campaign that formerly relied only on vaccination centers affected the speed of that campaign. Using data on vaccine deliveries and vaccinations given in Germany, we find considerable differences across federal states in terms of efficiency, defined as the ability to administer the most vaccinations out of a given number of available doses. Back-of-the-envelope calculations for January to May 2021 show that vaccinations would have been 3.4–6.9% higher if all federal states had adopted a similar ratio between vaccinations given and vaccines stored, as the most efficient states did. This corresponds to 1.7–3.3% of Germany’s total population. In terms of our second research goal, we find evidence that the integration of doctors’ offices into the vaccination campaign significantly increased the ratio of vaccinations administered out of a given stock of vaccine doses. On average, there appears to be a structural break in this ratio after doctors’ offices were integrated into the vaccination campaign on 5 April 2021. On average, an additional 11.6 out of 100 available doses were administered each week compared to the period prior to that date. We conclude that there are considerable regional differences in the efficiency of the vaccination roll-out. Systematic efficiency analyses are one step to detecting inefficiencies and to identify best practices that can be adopted to eventually speed up the vaccination roll-out in a country.
With about 6 million visitors, the 2022 Oktoberfest in Germany has been one of the largest in-person social events following the COVID-19 pandemic. Despite high vaccination rates in Germany at that time, health authorities pointed out the high risk of getting infected at such events. Using a unique dataset, we estimate the causal impact of the Oktoberfest on the spread of infection by applying an event study design. Our results imply a significant increase in the infection rates during and after Oktoberfest, especially in the age cohorts 15-34 and 35-59. However, the case rate drops relatively quickly after Oktoberfest. We also find little to no effect of the fair on the infection rates of the remaining age cohorts below 15 and above 60 years of age. A robustness check using the hospitalization rate as dependent variable confirms those results. Our findings have important implications for regulations of large social events in times of COVID-19, when the share of vaccinated people in the population is already high.